The changing face of corporate venturing in biotechnology

November 9, 2021 Siddhant Goyal

Date of Publication: Oct 10, 2012

Author: Georg von Krogh, Boris Battistini & Pius Baschera

Summary:

Corporate venture funds are playing an increasingly important role in supporting life science commercialization.

Link to Full Reading:

https://www.nature.com/articles/nbt.2383